Prevalence and predictors of nocturnal polyuria in females with overactive bladder syndrome
- PMID: 34762173
- DOI: 10.1007/s00345-021-03865-5
Prevalence and predictors of nocturnal polyuria in females with overactive bladder syndrome
Abstract
Purpose: To describe the prevalence and predictors of nocturnal polyuria (NP) in women with overactive bladder syndrome (OAB).
Methods: Between July 2009 and January 2018, women with OAB were enrolled. NP was defined when the nocturnal polyuria index (NPI) (nighttime voided volume over 24-h voided volume) was > 33% (NPI33) in women ≥ 65 years-old and > 20% (NPI20) in women < 65 years old. Repeated analysis was also performed for NP defined by the NPI33 definition at all ages.
Results: A total of 1071 women with OAB were analyzed. The overall prevalence of NP was 30% (319/1071), with the highest prevalence in women in the perimenopausal period (46-50 years old), while NP was diagnosed by age-dependent NPI. The overall prevalence of NP was 12% (128/1071), with an increasing trend with increasing age, while NP was diagnosed by the NPI33 definition only. Daytime frequency and nocturia episodes were both predictors for NP in both definitions. Receiver operating characteristic curve analysis revealed that more than 5 nocturia episodes noted in the 3-day bladder diary were an optimal cutoff value to predict nocturnal polyuria [(sensitivity = 85.6%, specificity = 61.0%; area = 0.80, 95% CI 0.77-0.82) and (sensitivity = 88.3%, specificity = 65.9%; area = 0.83, 95% CI 0.80-0.85), respectively, in the two definitions].
Conclusions: NP is common in women with OAB, especially in women with more than 5 nocturia episodes in their 3-day bladder diaries, and adjuvant therapy for better treatment efficacy is needed.
Keywords: Bladder diary; Nocturia; Nocturnal polyuria; Overactive bladder syndrome.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Hsiao SM, Lin HH (2018) Medical treatment of female overactive bladder syndrome and treatment-related effects. J Formos Med Assoc 117:871–878. https://doi.org/10.1016/j.jfma.2018.01.011 - DOI - PubMed
-
- Stewart WF, Van Rooyen JB, Cundiff GW et al (2003) Prevalence and burden of overactive bladder in the United States. World J Urol 20:327–336. https://doi.org/10.1007/s00345-002-0301-4 - DOI - PubMed
-
- Haylen BT, de Ridder D, Freeman RM et al (2010) An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J 21:5–26. https://doi.org/10.1002/nau.20798 - DOI - PubMed
-
- Hashim H, Blanker MH, Drake MJ et al (2019) International Continence Society (ICS) report on the terminology for nocturia and nocturnal lower urinary tract function. Neurourol Urodyn 38:499–508. https://doi.org/10.1002/nau.23917 - DOI - PubMed
-
- Hetta J (1999) The impact of sleep deprivation caused by nocturia. BJU Int 84(Suppl 1):27–28. https://doi.org/10.1046/j.1464-410x.84.s1.3.x - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous